PATENT CLAIM ANALYSIS

Application Number: 16001318
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-11
Patent Classification: ["514", "001000"]

Abstract:
The present disclosure in various embodiments teaches methods of treating patients in need of treatment with a Factor Xa inhibitor, and who are also concomitantly administered verapamil.

Claim (Index 20):
The method of  claim 1 , wherein the condition is selected from the group consisting of:\n reducing the risk of stroke and systemic embolism in patients with non valvular atrial fibrillation, treating deep vein thrombosis (DVT), treating pulmonary embolism (PE), reducing the risk of DVT, and reducing the risk of PE, the prophylaxis of DVT which leads to PE in patients undergoing knee or hip replacement therapy, and the management of essential hypertension.

Metadata:
- Claim Count in Document: 87.0
- Percentile: 94.0
- Lexical Diversity: 1.07407
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13128459', '13184704', '13454286', '13454255', '12688038']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7735397117071242
- 35 USC 102 Novelty (BERT): 0.5177003426923623
- Combined Prediction Score: 0.747955774805648
- Mean Citation Score: 244.7395
- Max Citation Score: 258.22217
- Similarity Product: 159.59919356202718

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test